5Indexed trials
drug · Product Intelligence
Phenytoin
Pipeline Intelligence
Phenytoin: 5 indexed trials, 5 sponsors; 0 linked Orange Book patents and 19 FDA-linked events where matched.
5Sponsors
0Orange Book patent links
19FDA-linked events
Development evidence
NCT00004403Johns Hopkins University · epilepsyNA
NCT00610532Jim McAuley · epilepsyPHASE4
NCT01451593University College, London · multiple_sclerosisPHASE2
NCT01730313Centers for Disease Control and Prevention · epilepsyPHASE2
NCT02283827Bial - Portela C S.A. · epilepsyPHASE1
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALEXTENDED PHENYTOIN SODIUM · 2026-01-02
FDA_APPROVALEXTENDED PHENYTOIN SODIUM · 2019-09-30
FDA_APPROVALEXTENDED PHENYTOIN SODIUM · 2015-06-10
FDA_APPROVALPHENYTOIN · 2014-11-28
FDA_APPROVALEXTENDED PHENYTOIN SODIUM · 2006-12-11
FDA_APPROVALPHENYTOIN SODIUM · 2006-09-13
FDA_APPROVALEXTENDED PHENYTOIN SODIUM · 2003-06-20
FDA_APPROVALPHENYTOIN · 2002-04-19
FDA_APPROVALPHENYTOIN SODIUM · 1992-11-27
FDA_APPROVALPHENYTOIN SODIUM · 1987-12-18
FDA_APPROVALPHENYTOIN SODIUM · 1987-10-13
FDA_APPROVALPHENYTOIN SODIUM · 1987-03-17
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.